
Is MiMedx (MDXG) stock Halal?
As of the September 2026 screening, MiMedx Group, Inc. (MDXG) meets every AAOIFI Shariah Standard No. 21 requirement: non-permissible income, interest-bearing investments and interest-bearing debt all sit within the thresholds, and there is no impermissible preference share structure. The dividend purification factor is 98.21%. The stock is re-screened every month.
MiMedx is a leading biopharmaceutical company specializing in regenerative medicine. The company's primary focus is on the development and commercialization of innovative bioimplants derived from human placental tissues. MiMedx's products are designed to enhance healing by leveraging the innate properties of placental tissue to treat a variety of conditions, including chronic and hard-to-heal wounds, surgical sites, and musculoskeletal injuries. These advanced solutions cater to the needs of healthcare providers across the wound care, ophthalmology, and orthopedics sectors. For Muslim investors, though, the most pressing question is simpler: is MiMedx a Halal investment?
Is MiMedx Shariah compliant?
Technology companies rarely fail AAOIFI screening on what they sell. Software, hardware and digital services are permissible business activities, so for a company like MiMedx the Shariah question moves to the balance sheet: how much of its market value sits in interest bearing debt, how much of its cash earns Riba in conventional deposits, and whether incidental income from impermissible sources creeps past 5% of revenue. These are exactly the ratios AAOIFI Shariah Standard No. 21 polices, and they move every month with the share price.
Does MiMedx pass the business activity test?
Yes. In the September 2026 screening MiMedx holds an overall PASS, which a stock only earns when its core business clears the activity screen. The watch item for technology names is incidental: cash returns and platform content can carry impermissible elements, which AAOIFI tolerates only below the thresholds.
Is MiMedx's income Halal?
Yes, within AAOIFI's tolerance. MiMedx's income from non-permissible sources stays below 5% of revenue in the September 2026 screening, and the small impure portion is handled through purification: the factor of 98.21% tells holders of MDXG what share of each dividend to keep and what remainder to donate to charity.
Does MiMedx meet AAOIFI's debt and investment ratio requirements?
Yes. Both caps hold this month: interest bearing investments and interest bearing debt each stay below 30% of market capitalisation. Because the caps move with the share price, our Shariah Supervisory Board has MDXG re-screened every month, and the result above always shows the latest verdict.
Tabadulat is an ADGM regulated brokerage whose license covers Shari'a Compliant Regulated Activities, as the FSRA permission names them. New to the terminology? Gharar and Maysir, Sukuk, Zakat and purification are all explained in plain English.
New to the four screens? Read Why a Halal Stock Screener Matters for Halal Investing



